RenovoRx, Inc. RNXT
1.66
(0.02)
(1.19%)
as of 25 Sep
- Market cap
- $75.8M
- P/E
- 0.0×
Follow RNXT
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(146.61%) | (225.62%) | (100.47%) | (125.23%) | |
| (104.58%) | (137.77%) | (81.85%) | (97.83%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(121.91%) | (187.92%) | (103.30%) | (136.20%) | |
Average Days of Receivables |
0.00 | 45.18 | 68.64 | 88.66 | |
Free Cash Flow per Share |
(0.28) | (0.31) | (0.30) | (0.25) | |
Free Cash Flow |
(10.40) | (10.97) | (11.30) | (11.94) | |
Capital Expenditures |
(0.01) | 0.00 | — | (0.07) | |
Piotroski F-Score |
1.00 | 4.00 | 4.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(57.30%) | (88.16%) | (47.83%) | (64.29%) | |
Accounts Receivable Turnover |
— | 12.34 | 5.71 | 4.69 | |
Accounts Payable Turnover |
0.39 | 0.47 | 0.30 | 0.40 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
1,050.28 | 891.85 | 1,288.44 | 1,026.27 | |
Days of Inventory on Hand |
328.74 | 210.96 | 436.39 | 453.88 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 558.24% | 393.22% | 284.87% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 626.63% | 549.76% | 484.77% | |
Share Based Compensation of Revenue |
0.00% | 112.82% | 87.04% | 76.97% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.94 | 0.98 | 0.92 | 0.97 | |
Depreciation/Fixed assets |
0.08 | 0.17 | 0.03 | 0.06 | |
Capex/Depreciation |
(14.00) | (1.00) | 0.00 | (11.83) | |
Revenue per Share |
0.00 | 0.03 | 0.04 | 0.04 | |
Operating CF per Share |
(0.28) | (0.31) | (0.30) | (0.25) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.04 | |
Net Profit Margin |
0.00% | (994.48%) | (823.98%) | (621.71%) |
Columns are period end dates